{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03824535",
            "orgStudyIdInfo": {
                "id": "IRB-46607"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2019-00177",
                    "type": "REGISTRY",
                    "domain": "CTRP (Clinical Trial Reporting Program)"
                },
                {
                    "id": "LUN0106",
                    "type": "OTHER",
                    "domain": "Stanford Cancer Institute Palo Alto"
                },
                {
                    "id": "IRB-46607",
                    "type": "OTHER",
                    "domain": "Stanford IRB"
                }
            ],
            "organization": {
                "fullName": "Stanford University",
                "class": "OTHER"
            },
            "briefTitle": "18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules",
            "officialTitle": "18F-FSPG PET/CT and Integrated Biomarkers for Early Lung Cancer Detection in Patients With Indeterminate Pulmonary Nodules",
            "therapeuticArea": [
                "Respiratory",
                "Other"
            ],
            "study": "fspg-pet-ct-in-diagnosing-early-lung-cancer-in-patients-with-lung-nodules"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "startDateStruct": {
                "date": "2019-02-04",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-01-29",
            "studyFirstSubmitQcDate": "2019-01-29",
            "studyFirstPostDateStruct": {
                "date": "2019-01-31",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-01",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-05",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "Andrei Iagaru",
                "investigatorTitle": "Associate Professor of Radiology (Nuclear Medicine)",
                "investigatorAffiliation": "Stanford University"
            },
            "leadSponsor": {
                "name": "Andrei Iagaru",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Canary Foundation",
                    "class": "OTHER"
                },
                {
                    "name": "Boston University",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "This phase II trial studies how well 18F-FSPG positron emission tomography (PET)/computed tomography (CT) work in diagnosing early lung cancer in patients with lung nodules. PET imaging with an imaging agent called 18F-FDG is often used in combination with a PET/CT scanner to evaluate cancers. Giving 18F-FSPG before a PET/CT scan may work better in helping researchers diagnose early lung cancer in patients with lung nodules.",
            "detailedDescription": "PRIMARY OBJECTIVES:\n\nI. Comparison of fluorine F 18 L-glutamate derivative BAY94-9392 (18F-FSPG) accumulation with fludeoxyglucose F-18 (18F-FDG) accumulation to assess whether (4S)-4-(3-18F-Fluoropropyl)-L-Glutamate (18F-FSPG)-PET is better at discriminating between benign and malignant nodules.\n\nSECONDARY OBJECTIVES:\n\nI. To develop and validate early lung cancer detection biomarkers that would directly impact the growing need to integrate imaging and non-invasive molecular diagnostics for indeterminate pulmonary nodules and allow physicians to avoid unnecessary invasive procedures in patients with benign lung disease.\n\nOUTLINE:\n\nPatients receive 18F-FSPG intravenously (IV) and, undergo a PET/CT scan over 30-60 minutes. Within 24 hours-14 days, patients receive 18F-FDG and undergo a second PET/CT scan over 30-60 minutes.\n\nAfter completion of study, patients are followed up within 24-72 hours."
        },
        "conditionsModule": {
            "conditions": [
                "Cigarette Smoker",
                "Current Smoker",
                "Former Smoker",
                "Multiple Pulmonary Nodules",
                "Pulmonary Nodule"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "DIAGNOSTIC",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 50,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Diagnostic (18F-FSPG PET/CT, 18F-FDG PET/CT)",
                    "type": "EXPERIMENTAL",
                    "description": "Patients receive 18F-FSPG IV and, undergo a PET/CT scan over 30-60 minutes. Within 24 hours-14 days, patients receive 18F-FDG IV and undergo a second PET/CT scan over 30-60 minutes.",
                    "interventionNames": [
                        "Procedure: Computed Tomography",
                        "Drug: Fludeoxyglucose F-18",
                        "Drug: Fluorine F 18 L-glutamate Derivative BAY94-9392",
                        "Procedure: Positron Emission Tomography"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "PROCEDURE",
                    "name": "Computed Tomography",
                    "description": "Undergo PET/CT",
                    "armGroupLabels": [
                        "Diagnostic (18F-FSPG PET/CT, 18F-FDG PET/CT)"
                    ],
                    "otherNames": [
                        "CAT",
                        "CAT Scan",
                        "Computerized Axial Tomography",
                        "computerized tomography",
                        "CT",
                        "CT SCAN",
                        "tomography"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Fludeoxyglucose F-18",
                    "description": "Given IV",
                    "armGroupLabels": [
                        "Diagnostic (18F-FSPG PET/CT, 18F-FDG PET/CT)"
                    ],
                    "otherNames": [
                        "18-FDG",
                        "FDG",
                        "fludeoxyglucose F 18",
                        "Fludeoxyglucose F18",
                        "Fluorine-18 2-Fluoro-2-deoxy-D-Glucose",
                        "Fluorodeoxyglucose F18"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Fluorine F 18 L-glutamate Derivative BAY94-9392",
                    "description": "Given IV",
                    "armGroupLabels": [
                        "Diagnostic (18F-FSPG PET/CT, 18F-FDG PET/CT)"
                    ],
                    "otherNames": [
                        "(S)-4-(3-18F-fluoropropyl)-L-glutamic Acid",
                        "18F-FSPG",
                        "BAY94-9392"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "Positron Emission Tomography",
                    "description": "Undergo PET/CT",
                    "armGroupLabels": [
                        "Diagnostic (18F-FSPG PET/CT, 18F-FDG PET/CT)"
                    ],
                    "otherNames": [
                        "Medical Imaging, Positron Emission Tomography",
                        "PET",
                        "PET Scan",
                        "Positron Emission Tomography Scan",
                        "Positron-Emission Tomography",
                        "proton magnetic resonance spectroscopic imaging"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Fluorine F 18 L-glutamate derivative BAY94-9392 (18F-FSPG) specificity for malignant lung nodules",
                    "description": "18F-FSPG accumulation in lung nodules will be assessed. The observed FSPG specificity will be assessed against a fixed value of 75%.",
                    "timeFrame": "Up to 5 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Improved performance of prediction model for lung nodules",
                    "description": "Improved performance is defined as a p \\< 0.05 increase in the C statistic determined using DeLong test for correlated receiver operating characteristic (ROC) curves.",
                    "timeFrame": "Up to 5 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Pulmonary nodule between the size of 7 to 30 mm. Subjects with multiple nodules may be eligible if the dominant nodule is 7 to 30 mm\n* Undergoing standard of care 18F-FDG PET imaging (for indeterminate pulmonary nodule)\n* Current or former cigarette smoker, with \\>= 20 pack years\n* Documented informed consent\n\nExclusion Criteria:\n\n* History or previous diagnosis of lung cancer\n* Cancer diagnosis within the last 5 years\n* Pregnant or nursing",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "45 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Mahima Goel",
                    "role": "CONTACT",
                    "phone": "650-723-0371",
                    "email": "mahimag@stanford.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Carina M Aparici",
                    "affiliation": "Stanford Cancer Institute Palo Alto",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Stanford Cancer Institute Palo Alto",
                    "status": "RECRUITING",
                    "city": "Palo Alto",
                    "state": "California",
                    "zip": "94304",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mahima Goel",
                            "role": "CONTACT",
                            "phone": "650-723-0371",
                            "email": "mahimag@stanford.edu"
                        },
                        {
                            "name": "Carina M Aparici, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.44188,
                        "lon": -122.14302
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "documentSection": {
        "largeDocumentModule": {
            "largeDocs": [
                {
                    "typeAbbrev": "ICF",
                    "hasProtocol": false,
                    "hasSap": false,
                    "hasIcf": true,
                    "label": "Informed Consent Form",
                    "date": "2021-11-30",
                    "uploadDate": "2022-06-13T13:57",
                    "filename": "ICF_000.pdf",
                    "size": 353853
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000055613",
                    "term": "Multiple Pulmonary Nodules"
                }
            ],
            "ancestors": [
                {
                    "id": "D000008175",
                    "term": "Lung Neoplasms"
                },
                {
                    "id": "D000012142",
                    "term": "Respiratory Tract Neoplasms"
                },
                {
                    "id": "D000013899",
                    "term": "Thoracic Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M28260",
                    "name": "Multiple Pulmonary Nodules",
                    "asFound": "Pulmonary Nodules",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14979",
                    "name": "Respiratory Tract Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M16658",
                    "name": "Thoracic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003847",
                    "term": "Deoxyglucose"
                },
                {
                    "id": "D000019788",
                    "term": "Fluorodeoxyglucose F18"
                },
                {
                    "id": "D000005459",
                    "term": "Fluorides"
                }
            ],
            "ancestors": [
                {
                    "id": "D000019275",
                    "term": "Radiopharmaceuticals"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000002327",
                    "term": "Cariostatic Agents"
                },
                {
                    "id": "D000020011",
                    "term": "Protective Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000000963",
                    "term": "Antimetabolites"
                },
                {
                    "id": "D000000998",
                    "term": "Antiviral Agents"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21686",
                    "name": "Fluorodeoxyglucose F18",
                    "asFound": "One year",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7043",
                    "name": "Deoxyglucose",
                    "asFound": "Cytomegalovirus",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8587",
                    "name": "Fluorides",
                    "asFound": "Tunnel",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21258",
                    "name": "Radiopharmaceuticals",
                    "relevance": "LOW"
                },
                {
                    "id": "M21869",
                    "name": "Protective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4281",
                    "name": "Antimetabolites",
                    "relevance": "LOW"
                },
                {
                    "id": "M4314",
                    "name": "Antiviral Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "T5",
                    "name": "Glutamic Acid",
                    "asFound": "Psychometric",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "AA",
                    "name": "Amino Acids"
                }
            ]
        }
    },
    "hasResults": false
}